Ixazomib-Based Maintenance Therapy Improves Prognosis of Patients with Multiple Myeloma: A Real-World Study

被引：0
|
作者：
Hong, Xiuli [1 ]
Chen, Jie [1 ]
Lu, Jingyuan [1 ]
Lu, Quanyi [1 ]
机构：
[1] Xiamen Univ, Zhongshan Hosp, Sch Med, Dept Hemotol, Xiamen, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-201297
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7014 / 7015
页数：2
相关论文
共 50 条
  • [31] Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
    Heinz Ludwig
    Wolfram Poenisch
    Stefan Knop
    Alexander Egle
    Martin Schreder
    Daniel Lechner
    Roman Hajek
    Eberhard Gunsilius
    Karl Jochen Krenosz
    Andreas Petzer
    Katja Weisel
    Dietger Niederwieser
    Hermann Einsele
    Wolfgang Willenbacher
    Thomas Melchardt
    Richard Greil
    Niklas Zojer
    British Journal of Cancer, 2019, 121 : 751 - 757
  • [32] Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
    Evangelos Terpos
    Karthik Ramasamy
    Nadjoua Maouche
    Jiri Minarik
    Ioannis Ntanasis-Stathopoulos
    Eirini Katodritou
    Matthew W. Jenner
    Hana Plonkova
    Maria Gavriatopoulou
    Grant D. Vallance
    Tomas Pika
    Maria Kotsopoulou
    Jaimal Kothari
    Tomas Jelinek
    Efstathios Kastritis
    Robin Aitchison
    Meletios A. Dimopoulos
    Athanasios Zomas
    Roman Hajek
    Annals of Hematology, 2020, 99 : 1049 - 1061
  • [33] Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey
    Bakirtas, Mehmet
    Dal, Mehmet Sinan
    Yigenoglu, Tugce Nur
    Giden, Asli Odabasi
    Serin, Istemi
    Basci, Semih
    Kalpakci, Yasin
    Korkmaz, Serdal
    Ekinci, Omer
    Albayrak, Murat
    Basturk, Abdulkadir
    Ozatli, Duzgun
    Dogu, Mehmet Hilmi
    Hacibekiroglu, Tuba
    Cakar, Merih Kizil
    Ulas, Turgay
    Miskioglu, Mine
    Gulturk, Emine
    Eser, Bulent
    Altuntas, Fevzi
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (06) : 563 - 569
  • [34] Ixazomib-Based Induction Followed By Single-Agent Ixazomib Maintenance in Transplant Ineligible, Newly Diagnosed Multiple Myeloma Patients: Updated Results of the EMN10-Unito Trial
    Mina, Roberto
    Larocca, Alessandra
    Corradini, Paolo
    Cascavilla, Nicola
    Liberati, Anna Marina
    Pescosta, Norbert
    Fazio, Francesca
    Ciccone, Giovannino
    Capra, Andrea
    Patriarca, Francesca
    Bernardini, Annalisa
    Scalabrini, Delia Rota
    Cea, Michele
    Zambello, Renato
    Baraldi, Anna
    Belotti, Angelo
    Boccadoro, Mario
    Bringhen, Sara
    BLOOD, 2020, 136
  • [35] Efficacy and safety of ixazomib maintenance therapy for patients with multiple myeloma: a meta-analysis
    Chen, Huixian
    Wang, Yongjing
    Shao, Chunchun
    Sun, Chenxi
    Zheng, Chengyun
    HEMATOLOGY, 2021, 26 (01) : 1031 - 1039
  • [36] IXAZOMIB-BASED INDUCTION FOLLOWED BY SINGLE-AGENT IXAZOMIB MAINTENANCE IN TRANSPLANT INELIGIBLE, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: UPDATED RESULTS OF THE EMN10-UNITO TRIAL
    Mina, R.
    Larocca, A.
    Corradini, P.
    Cascavilla, N.
    Liberati, A. M.
    Pescosta, N.
    Fazio, F.
    Ciccone, G.
    Capra, A.
    Patriarca, F.
    Rota-Scalabrini, D.
    Gerace, D.
    Priola, C.
    Cea, M.
    Zambello, R.
    Monaco, F.
    Belotti, A.
    Cellini, C.
    Paris, L.
    Grasso, M.
    Aquino, S.
    Casaluci, G. Margiotta
    De Sabbata, G.
    Ballanti, S.
    Offidani, M.
    Cavo, M.
    Boccadoro, M.
    Bringhen, S.
    HAEMATOLOGICA, 2021, 106 (10) : 94 - 94
  • [37] Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment
    Cho, Hee Jeong
    Lee, Myung-Won
    Lee, Yunji
    Lee, Jungmin
    Lee, Jae Hoon
    Uhm, Hyun-Seok
    Jung, Jong Heon
    Yhim, Ho-Young
    Yoon, Dok
    Cho, Hyungwoo
    Yoon, Sung-Soo
    Byun, Ja Min
    Do, Young Rok
    Kim, Hyo Jung
    Lee, Ji Hyun
    Lim, Sung-Nam
    Kang, Hye Jin
    Lee, Ho Sup
    Kim, Yundeok
    Lee, Hee jeong
    Lee, Sang Min
    Moon, Joon Ho
    Kim, Kihyun
    BLOOD, 2024, 144 : 4698 - 4699
  • [38] Thalidomide maintenance therapy improves survival in patients with multiple myeloma
    Nature Clinical Practice Oncology, 2007, 4 (2): : 67 - 67
  • [39] Maintenance, therapy with thalidomide improves survival in patients with multiple myeloma
    Attal, Michel
    Harousseau, Jean-Luc
    Leyvraz, Serge
    Doyen, Chantal
    Hulin, Cyrille
    Benboubker, Lofti
    Agha, Ibrahim Yakoub
    Bourhis, Jean-Henri
    Garderet, Laurent
    Pegourie, Brigitte
    Dumontet, Charles
    Renaud, Marc
    Voillat, Laurent
    Berthou, Christian
    Marit, Gerald
    Monconduit, Mathieu
    Caillot, Denis
    Grobois, Bernard
    Avet-Loiseau, Herve
    Moreau, Philippe
    Facon, Thierry
    BLOOD, 2006, 108 (10) : 3289 - 3294
  • [40] Efficacy Analysis of Ixazomib-Based Regimens Based on Dynamic Frailty Assessment in Elderly and Frail Patients with Newly Diagnosed Multiple Myeloma
    Xu, Jianmei
    Xue, Hua
    Zhao, Songying
    Wang, Jing
    Guo, Huimei
    Zhang, Jiangbo
    Liu, Jia
    Hua, Luoming
    Tian, Mingjie
    Zhao, Mingfeng
    BLOOD, 2023, 142
12345